skip to content

Department of Oncology



Professor Rebecca Fitzgerald OBE FMedSci FRS is amongst 90 exceptional researchers from around the world elected as Fellows and Foreign Members of the Royal Society this year.

The elected Fellows are leaders in their fields and are recognised for their invaluable contributions to science.

Rebecca is Professor of Cancer Prevention with the Department of Oncology and Director of the Early Cancer Institute at the University of Cambridge.

With a special interest in Barrett's oesophagus and its progression to oesophageal adenocarcinoma, Rebecca has shown that Barrett's oesophagus is a necessary step for cancer development and has defined the alterations that demarcate the transition from benign to malignant transformation.

Rebecca has applied these insights to develop a diagnostic test for Barrett's oesophagus, called Cytopsonge-TFF3, that she has taken from proof of concept through to clinical implementation. Cytopsonge-TFF3 is a first in class non-endoscopic approach to early diagnosis for patients with Barrett's and early stage OAC with applicability on a population scale.

Drawn from across academia, industry and wider society, the new intake spans disciplines as varied as pioneering treatments for Huntington’s Disease, developing the first algorithm for video streaming, generating new insights into memory formation, and studying the origins and evolution of our universe.

Sir Adrian Smith, President of the Royal Society, said: “I am pleased to welcome such an outstanding group into the Fellowship of the Royal Society.

This new cohort have already made significant contributions to our understanding of the world around us and continue to push the boundaries of possibility in academic research and industry.”